Actively Recruiting

Phase 4
Age: 18Years +
FEMALE
Healthy Volunteers
NCT05058872

Contraceptive Hormone and Reward Measurement (CHARM Study)

Led by University of Colorado, Denver · Updated on 2024-11-04

144

Participants Needed

1

Research Sites

286 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Purpose of this study: The purpose of this study is to learn more about how hormonal oral contraceptives affect brain processes and emotional wellbeing. Procedures: If participants agree to participate, the following will happen: 1. Eligibility visit (remote screening session) 2. If participants are eligible to participate in the study, they will be placed in one of two groups. If they are in the first group, they will be asked to take an oral contraception pill ("study drug") every day for 21 days. If they are in the second, they will take a placebo every day for 21 days. A placebo is a pill that looks like medicine but is not real and will have no medical effect on participants. Participants will not get to choose which group they are in, nor will they be told which group they are in. 3. During the three-week period in which participants will take either the study drug or placebo, they will be asked to complete daily check-in surveys on their computer or mobile device. 4. Participants will be asked to attend two additional visits over the course of about three weeks. At these visits, participants will be asked to undergo a urine drug screen, a blood draw, and a magnetic resonance imaging (MRI). They will also be asked to complete behavioral questionnaires.

CONDITIONS

Official Title

Contraceptive Hormone and Reward Measurement (CHARM Study)

Who Can Participate

Age: 18Years +
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 18 and older
  • Right-handed
  • Assigned female at birth
  • Regular 21-35 day menstrual cycles for the past 6 months per self-report
  • In generally good health per self-report; stable chronic medical conditions may be allowed at investigator discretion
  • Willingness to abstain from intercourse or use non-hormonal backup contraception during the study
  • Negative urine drug screen at baseline except prescribed marijuana or benzodiazepine as sleep aid
  • Ability to abstain from caffeine and/or cannabis for 2 hours before MRI visits
  • Access to reliable internet or cell phone data for daily questionnaires
  • For remote screening, access to reliable internet, a computer, and private space
Not Eligible

You will not qualify if you...

  • History or presence of severe or unstable physical, neurological, or psychiatric disorders
  • Lifetime history of psychotic disorders
  • Substance use disorder not in remission for at least one year, except mild or cannabis-only disorders at investigator discretion
  • Category 3 or 4 conditions or medications per CDC eligibility criteria for combined hormonal contraceptives
  • Irregular menstrual periods
  • Current tobacco smoking or smoking within past year
  • Personal or family history of venous thromboembolism
  • Known hypertensive disorder
  • Current or past malignancy
  • Migraines with aura
  • Systolic blood pressure ≥140 or diastolic ≥90 at baseline
  • Currently nursing an infant
  • Known chromosomal or hormonal disorder affecting sex steroids
  • Use of hormonal contraceptives currently or in past 3 months or medications affecting sex hormones
  • Current pregnancy or pregnancy/delivery within past 6 months
  • Intention to become pregnant during study
  • Current use of psychotropic medications
  • Claustrophobia
  • Metal in body unsafe for MRI
  • Weight over 300 pounds
  • Conditions making MRI unsafe (e.g. aneurysm clip, pacemaker)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Colorado Denver Anschutz Medical Campus

Aurora, Colorado, United States, 80045

Actively Recruiting

Loading map...

Research Team

A

Andrew M Novick, MD PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here